WF and PR OCTA in Diabetic Retinopathy

Active, not recruitingOBSERVATIONAL

Enrollment

290

Participants

Timeline

Start Date

August 30, 2017

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2027

Conditions

Diabetic Retinopathy

Trial Locations (1)

Oregon Health & Science University, Portland

All Listed Sponsors

lead

Oregon Health and Science University

OTHER

NCT03922932 - WF and PR OCTA in Diabetic Retinopathy | Biotech Hunter | Biotech Hunter